5 Oorjita research notes discuss Sun Pharmaceutical.
Mankind Pharma is India’s 4th largest pharmaceutical company by domestic market value, with a diversified presence across prescription pharmaceuticals, consumer healthcare/OTC, and exports.
Sustainability above 26,150 levels and volume confirmation will determine whether yesterday's breakout has conviction or if profit-booking emerges at psychological 26,200+ zones.
Large-cap defensives with muted price action but explosive delivery surges = silent institutional accumulation ahead of Q3/Q4 positioning.
weakness), but our directional call and opening prediction failed. This demonstrates the importance of risk management over market timing - subscribers who followed our tight stop-losses at 25,980 were protected despite the directional miss.
